N-(tert-Butyl)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 97%, 1g

3-((2,5-Difluorophenyl)thio)butan-2-one, 95%, 2.5g

4,4'-(4,4'-BIPHENYLDIYLDIIMINO)BIS(4-OXO-2-BUTENOIC ACID), 95.0%, 1g

trans-tert-Butyl 4-aminocyclohexanecarboxylate, 97.0%, 10g

8-OXABICYCLO[3.2.1]OCTAN-3-ONE, 95.0%, 1g

n-(2-Aminoethyl)-3-({2-[(2-aminoethyl)carbamoyl]ethyl}({2-[bis({2-[(2-aminoethyl)carbamoyl]ethyl})amino]ethyl})amino)propanamide, 98%, 1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzonitrile, 95.0%, 5g

Ethyl 2-((tert-butoxycarbonyl)amino)-1H-indole-3-carboxylate, 95+%, 1g

2-Methoxy-5-(trifluoromethyl)pyrimidine, 98%, 5g

trans-Dichlorodiamineplatinum(II), 95.0%, 100mg

Ethyl 3-(2-hydroxyphenyl)propanoate, 97%, 500mg

3-Chloro-2-fluoro-4-(hydroxymethyl)pyridine, 98%, 100mg

n-Butyl trifluoroacetate, 97.0%, 5g